نتایج جستجو برای: diethylcarbamazine

تعداد نتایج: 358  

Journal: :Tanzania health research bulletin 2006
W H Makunde M L Kamugisha R A Makunde M N Malecela-Lazaro A Y Kitua

Pre and post-diethylcarbamazine treatment clinical expression, microfilaraemia prevalence and cellular responses were investigated in individuals in Tanga, Tanzania. Fifty-seven male individuals (aged = 15 years old) were identified for further studies on IL-4, IL-6, IL-8. IFN-gamma, IL-beta, TNF-alpha and nitric oxide in plasma and hydrocoele fluid. Microfilarial prevalence in the examined ind...

Journal: :Circulation research 1984
C W Leffler J A Mitchell R S Green

We investigated the effects of exogenous leukotriene D4, synthesis inhibitors, and a leukotriene receptor antagonist upon chloralose anesthetized, mechanically ventilated, neonatal piglets with constant left pulmonary blood flow and upon piglets with uncontrolled pulmonary blood flow. Leukotriene D4 (100-10,000 ng, intravenously) caused dose-dependent increases in peak tracheal pressure, pulmon...

Journal: :Parasitology international 2006
I P Sunish R Rajendran T R Mani A Munirathinam R Reuben A P Dash

The impact of single dose mass drug administration of diethylcarbamazine (DEC), DEC with albendazole (ALB), and ivermectin (IVR) with albendazole, was examined on the human bancroftian filarial infections in village scale trials in south India, from a follow-up study after 2 years. The treatment arms administered with DEC alone and DEC+ALB demonstrated long-term benefits in reducing microfilara...

Journal: :The American journal of tropical medicine and hygiene 2008
Jennifer L Liang Jonathan D King Kazuyo Ichimori Thomas Handzel Molisamoa Pa'au Patrick J Lammie

American Samoa began a territory-wide mass drug administration (MDA) program with diethylcarbamazine and albendazole in 2000 after baseline surveys indicated that 16.5% of 2,989 residents were infected with Wuchereria bancrofti based on tests for circulating filarial antigen. Follow-up surveys were conducted in 2001, 2003, and 2006, using convenience samples of residents of sentinel villages. A...

Journal: :Bulletin of the World Health Organization 1999
C A Maxwell K Mohammed U Kisumku C F Curtis

A single campaign of mass treatment for bancroftian filariasis with diethylcarbamazine (DEC) in Makunduchi, a town in Zanzibar, United Republic of Tanzania, combined with elimination of mosquito breeding in pit latrines with polystyrene beads was followed by a progressive decline over a 5-year period in the microfilarial rate from 49% to 3%. Evidence that vector control had contributed to this ...

Journal: :The Lancet. Infectious diseases 2017
Michael A Irvine Wilma A Stolk Morgan E Smith Swaminathan Subramanian Brajendra K Singh Gary J Weil Edwin Michael T Deirdre Hollingsworth

BACKGROUND Lymphatic filariasis is targeted for elimination as a public health problem by 2020. The principal approach used by current programmes is annual mass drug administration with two pairs of drugs with a good safety profile. However, one dose of a triple-drug regimen (ivermectin, diethylcarbamazine, and albendazole) has been shown to clear the transmissible stage of the helminth complet...

Journal: :The Ceylon medical journal 2008
N K Gunawardena N D D M Amarasekera A Pathmeswaran N R de Silva

BACKGROUND In July 2006 Sri Lanka completed 5 rounds of annual mass drug administration (MDA) with diethylcarbamazine citrate (DEC) and albendazole as part of its national programme for elimination of lymphatic filariasis (LF). Albendazole is highly effective against soil-transmitted helminths (STH). This study was carried out to assess the effect of repeated annual MDA on STH infections in the...

2017
Fasihah Taleo George Taleo Patricia M. Graves Peter Wood Sung Hye Kim Masayo Ozaki Hayley Joseph Brian Chu Alex Pavluck Aya Yajima Wayne Melrose Kazuyo Ichimori Corinne Capuano

BACKGROUND Vanuatu was formerly highly endemic for lymphatic filariasis (LF), caused by Wuchereria bancrofti and transmitted by Anopheles mosquitoes. After a baseline survey showing 4.8% antigen prevalence in 1998, the country conducted nationwide (in one implementation unit) annual mass drug administration (MDA) with albendazole and diethylcarbamazine citrate from 2000 to 2004 and achieved pre...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید